[1] Petricoin E F, Belluco C, Araujo R P, et al. The blood peptidome: a higher dimension of information content for cancer biomarker discovery[J]. Nat Rev Cancer, 2006, 6 (12):961-967
[2] Liu Y, Uboh C E, Soma L R, et al. Efficient use of retention time for the analysis of 302 drugs in equine plasma by liquid chromatography-MS/MS with scheduled multiple reaction monitoring and instant library searching for doping control[J]. Anal Chem, 2011, 83 (17):6834-6841
[3] Lee J H, Lim H, Kim D G, et al. Quantification of oltipraz using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in rat plasma[J]. J Pharm Biomed Anal, 2011, 56 (3):623-626
[4] Ang C S, Nice E C. Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces[J]. J Proteome Res, 2010, 9 (9):4346-4355
[5] Kuzyk M A, Smith D, Yang J, et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma[J]. Mol Cell Proteomics, 2009, 8 (8):1860-1877
[6] 赵焱, 应万涛, 钱小红. 质谱MRM技术在蛋白质组学研究中的应用[J]. 生命的化学（Zhao Yan, Ying Wan-Tao, Qian Xiao-Hong. Application of mass spectrometry MRM technology in proteome research[J].Chem Life）, 2008, 28 (2):210-213
[7] Ueda K, Saichi N, Takami S, et al. A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma[J]. PLoS One, 2011, 6 (4): e18567
[8] Sch?gger H. Tricine-SDS-PAGE[J]. Nat Protoc, 2006, 1 (1):16-22
[9] Zhang L, Jia X, Zhang X, et al. Alpha-1 antitrypsin variants in plasma from HIV-infected patients revealed by proteomic and glycoproteomic analysis[J]. Electrophoresis, 2010, 31 (20): 3437-3445
[10] Schulz-Knappe P, Zucht H D, Heine G, et al. Peptidomics: the comprehensive analysis of peptides in complex biological mixtures[J]. Comb Chem High Throughput Screen, 2001, 4 (2): 207-217
[11] Jiang X, Ye M, Zou H. Technologies and methods for sample pretreatment in efficient proteome and peptidome analysis[J]. Proteomics, 2008, 8 (4):686-705
[12] Aristoteli L P, Molloy M P, Baker M S. Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery[J]. J Proteome Res, 2007, 6 (2):571-581
[13] Zheng X, Baker H, Hancock W. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer[J]. J Chromatogr A, 2006, 1120 (1-2):173-184
[14] Zougman A, Pilch B, Podtelejnikov A, et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome[J]. J Proteome Res, 2008, 7 (1):386-399
[15] Fiedler G M, Baumann S, Leichtle A, et al. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry[J]. Clin Chem, 2007, 53 (3):421-428
[16] Villanueva J, Philip J, Entenberg D, et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry[J]. Anal Chem, 2004, 76 (6): 1560-1570
[17] Tucholska M, Scozzaro S, Williams D, et al. Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption/ionization and electrospray ionization hybrid quadrupole time-of-flight[J].Anal Biochem,2007,370(2):228- 245
[18] Chertov O, Biragyn A, Kwak L W, et al. Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry[J]. Proteomics, 2004, 4 (4):1195-1203
[19] Bertile F, Robert F, Delval-Dubois V, et al. Endogenous plasma peptide detection and identification in the rat by a combination of fractionation methods and mass spectrometry[J]. Biomark Insights, 2007, 2:385-401